Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation (Tables)

v3.22.1
Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Equity Compensation Plan by Arrangements

The following table contains information about the Company’s stock plan at March 31, 2022:

 

    Awards
Reserved for
Issuance
    Awards
Issued &
Exercised
    Awards
Available
for Grant
 
2013 Equity Compensation Plan     45,603 *     32,429 **     13,174  
                         

 

* Increased by 8,651 thousand on January 1, 2022 representing 4% of the total number of shares of common stock outstanding on December 31, 2021.
** Includes both restricted stock grants and option grants
Schedule of Recognized Stock-Based Compensation

The Company recognized stock-based compensation expense (options and restricted share grants) in its condensed consolidated statements of operations as follows:

 

    Three Months Ended March 31,  
    2022     2021  
Research and Development   $ 550     $ 485  
General and Administrative     710       616  
Total   $ 1,260     $ 1,101  
Schedule of Stock Option Activity

The following table summarizes the activity for Company’ stock options for the three months ended March 31, 2022:

 

      Stock Options
Outstanding at December 31, 2021     28,184
Granted     225
Exercised     (195)
Forfeited     (100)
Cancelled     -
Expired     (366)
Outstanding at March 31, 2022     27,748